Press Releases & Statements

November 03, 2015

IPM Initiates First Trial of Novel HIV Prevention Drug for Women

Study in Belgium evaluates safety and tolerability of novel ARV-based women’s health technologySILVER SPRING, Md. (November 3, 2015) – The nonprofit International Partnership for Microbicides (IPM)... More »

September 21, 2015

IPM Welcomes New Board Members

New members bring expertise in health policy, product development and reproductive health SILVER SPRING, Md. (September 21, 2015) — The International Partnership for Microbicides (IPM) today... More »

September 12, 2014

IPM Welcomes Executive Vice President, Global Product Access Lynn Bodarky and Chief Financial Officer Mike Goldrich

New EVP to lead product introduction plans as IPM prepares for dapivirine ring clinical trial results; CFO to lead financial management and business development SILVER SPRING, Md. (September 12,... More »

May 08, 2014

IPM Receives Worldwide Rights to HIV Prevention Medicine

Expanded public-private collaboration with Janssen Pharmaceutical Companies of Johnson & Johnson will speed development and global distribution of dapivirine-based HIV prevention tools for women... More »

March 04, 2014

Two Studies Advance HIV Prevention Options for Women

First combination ARV vaginal ring and ARV film demonstrate safety, hold promise for further development BOSTON, Ma. (March 4, 2014) — Two early clinical studies of novel HIV prevention products for... More »

Pages